By Business/Source
Currency:USD
2025/Q3
Stock NameRevenueRatio
Business of identifying, developing and commercializing pharmaceutical products that target unmet2.26K100.00%
By Country/Region
Currency:USD
2024/FY
Stock NameRevenueRatio
United States9.78K100.00%